Cellgram-LC

BIOLOGICAL2 trials

Sponsors

Pharmicell Co., Ltd.

Conditions

Alcoholic Cirrhosis

Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

RecruitingNCT04689152

Pharmicell Co., Ltd.Alcoholic Cirrhosis

Start: 2021-03-02End: 2028-01-02Target: 200Updated: 2024-03-21

Unknown Phase

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

RecruitingNCT05093881

Pharmicell Co., Ltd.Alcoholic Cirrhosis

Start: 2021-08-24End: 2028-03-31Target: 100Updated: 2024-03-21